Literature DB >> 22467751

Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient.

Nicola Di Daniele1, Marianna De Francesco, Leano Violo, Alessio Spinelli, Giovanni Simonetti.   

Abstract

Haemodialysis patients show sympathetic hyperactivity. Hyperactivation of the sympathetic nervous system aggravates hypertension and it is related to left ventricular hypertrophy, heart failure, arrhythmias and atherogenesis. We report the first use of renal sympathetic nerve ablation for correction of uncontrolled hypertension in an end-stage renal disease patient on maintenance dialysis. We observed a progressive and sustained reduction of systemic blood pressure. Our case demonstrates the safety, the feasibility and the efficacy of this procedure. These findings suggest, however, that further clinical trials are needed into renal nerve radiofrequency ablation therapy for the treatment of hypertension and for the improvement of cardiovascular prognosis in this high-risk patient group.

Entities:  

Mesh:

Year:  2012        PMID: 22467751     DOI: 10.1093/ndt/gfs044

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

1.  Hypertension: Renal denervation in chronic kidney disease.

Authors:  Peter J Blankestijn; Jaap A Joles
Journal:  Nat Rev Nephrol       Date:  2012-07-03       Impact factor: 28.314

2.  Technical aspects of renal denervation in end-stage renal disease patients with challenging anatomy.

Authors:  Alessio Spinelli; Valerio Da Ros; Daniele Morosetti; Silvia D Onofrio; Valentina Rovella; Nicola Di Daniele; Giovanni Simonetti
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

Review 3.  Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options.

Authors:  Eva E Vink; Rosa L de Jager; Peter J Blankestijn
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

Review 4.  Revisiting renovascular imaging for renal sympathetic denervation: current techniques and applications.

Authors:  Uei Pua; Cher Heng Tan; Hee Hwa Ho; Julian Ko Beng Tan; Paul Jau Leong Ong
Journal:  Eur Radiol       Date:  2014-08-28       Impact factor: 5.315

5.  Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012.

Authors:  Thomas Weber; Robert Zweiker; Bruno Watschinger; Peter Grüner; Christian Koppelstätter; Mathias C Brandt; Jörg Horina; Helmut Brussee; Katharina Hohenstein; Thomas Lambert; Johann Auer; Uta C Hoppe
Journal:  Wien Klin Wochenschr       Date:  2012-11-27       Impact factor: 1.704

6.  Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease.

Authors:  Neil A Hoye; James C Baldi; Tracey L Putt; John B Schollum; Gerard T Wilkins; Robert J Walker
Journal:  Clin Kidney J       Date:  2013-11-08

7.  Renal denervation of the native kidneys for drug-resistant hypertension after kidney transplantation.

Authors:  Linn C Dobrowolski; Frederike J Bemelman; Ineke J M Ten Berge; Bert-Jan H van den Born; Jim A Reekers; C T Paul Krediet
Journal:  Clin Kidney J       Date:  2014-12-13

8.  Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research.

Authors:  Christian Ott; Axel Schmid; Tilmann Ditting; Paul A Sobotka; Roland Veelken; Michael Uder; Roland E Schmieder
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-03       Impact factor: 3.738

Review 9.  Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity.

Authors:  Maria Paola Canale; Simone Manca di Villahermosa; Giuliana Martino; Valentina Rovella; Annalisa Noce; Antonino De Lorenzo; Nicola Di Daniele
Journal:  Int J Endocrinol       Date:  2013-10-31       Impact factor: 3.257

10.  Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease.

Authors:  Alessandro Mauriello; Valentina Rovella; Lucia Anemona; Francesca Servadei; Elena Giannini; Pierluigi Bove; Alessandro Anselmo; Gerry Melino; Nicola Di Daniele
Journal:  J Am Heart Assoc       Date:  2015-11-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.